Equities

Merck Tbk PT

MERK:JKT

Merck Tbk PT

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (IDR)3,500.00
  • Today's Change-110.00 / -3.05%
  • Shares traded40.50k
  • 1 Year change-20.09%
  • Beta1.1258
Data delayed at least 10 minutes, as of Nov 08 2024 09:11 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of IDR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments201,437170,428196,343
Total Receivables, Net127,760238,852282,823
Total Inventory377,197369,096270,960
Prepaid expenses11,58217,05817,997
Other current assets, total217153--
Total current assets718,194795,587768,123
Property, plant & equipment, net216,880221,582234,197
Goodwill, net------
Intangibles, net1,1428891,121
Long term investments------
Note receivable - long term----0
Other long term assets1,9201,440840
Total assets957,8141,037,6471,026,267
LIABILITIES
Accounts payable21,251105,83783,879
Accrued expenses14,25627,62228,780
Notes payable/short-term debt000
Current portion long-term debt/capital leases6,9376,4537,163
Other current liabilities, total82,58799,162163,110
Total current liabilities125,031239,074282,931
Total long term debt11,1969,73013,119
Total debt18,13316,18320,282
Deferred income tax------
Minority interest------
Other liabilities, total25,70831,60146,172
Total liabilities161,935280,406342,223
SHAREHOLDERS EQUITY
Common stock22,40022,40022,400
Additional paid-in capital17,56217,56217,562
Retained earnings (accumulated deficit)755,917717,280644,082
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity795,879757,242684,044
Total liabilities & shareholders' equity957,8141,037,6471,026,267
Total common shares outstanding448448448
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.